191 related articles for article (PubMed ID: 18444365)
21. The rationale for the use of drugs in the treatment of diabetes mellitus.
Kryston LJ; Shaw RA
Semin Drug Treat; 1974; 3(4):365-75. PubMed ID: 4207077
[No Abstract] [Full Text] [Related]
22. [Pitfalls in treatment with oral antidiabetic agents].
Perusicová J
Vnitr Lek; 1998 Jan; 44(1):30-5. PubMed ID: 9750481
[TBL] [Abstract][Full Text] [Related]
23. [The use of oral antidiabetics].
Kangas T
Duodecim; 1974; 90(4):282-94. PubMed ID: 4603906
[No Abstract] [Full Text] [Related]
24. [Experimental and clinical pharmacology of oral antidiabetics].
Cuomo V; Marino A
Clin Ter; 1972 Sep; 62(6):505-52. PubMed ID: 4674507
[No Abstract] [Full Text] [Related]
25. Oral treatment in diabetes.
Stowers JM
Clin Endocrinol Metab; 1972 Nov; 1(3):721-50. PubMed ID: 4204135
[No Abstract] [Full Text] [Related]
26. [Diabetes therapy using oral antidiabetics].
Hasslacher C; Wahl P
Z Allgemeinmed; 1972 Apr; 48(12):583-7. PubMed ID: 5034166
[No Abstract] [Full Text] [Related]
27. [Peroral antidiabetics].
Johansen K
Ugeskr Laeger; 1982 Mar; 144(11):811-3. PubMed ID: 7101513
[No Abstract] [Full Text] [Related]
28. Oral hypoglycaemic agents.
Peden N; Newton RW; Feely J
Br Med J (Clin Res Ed); 1983 May; 286(6377):1564-7. PubMed ID: 6405890
[No Abstract] [Full Text] [Related]
29. [Evaluation of a new sulfonylurea, glipizide, in the treatment of diabetes mellitus].
Ninni M; Castelletta L
Minerva Med; 1973 Oct; 64(71):3725-31. PubMed ID: 4588364
[No Abstract] [Full Text] [Related]
30. [Role of oral hypoglycemic agents in the therapeutic approach to diabetic obesity].
Albert J; Ekoé JM
Sem Hop; 1983 Sep; 59(29-30):2135-40. PubMed ID: 6312587
[TBL] [Abstract][Full Text] [Related]
31. Diabetes under control: Understanding oral antidiabetic agents.
Longo R
Am J Nurs; 2010 Feb; 110(2):49-52. PubMed ID: 20107402
[No Abstract] [Full Text] [Related]
32. Type 2 diabetes and oral antihyperglycemic drugs.
Mizuno CS; Chittiboyina AG; Kurtz TW; Pershadsingh HA; Avery MA
Curr Med Chem; 2008; 15(1):61-74. PubMed ID: 18220763
[TBL] [Abstract][Full Text] [Related]
33. [Oral antidiabetics today].
Aro A
Duodecim; 1981; 97(12):837-47. PubMed ID: 7297451
[No Abstract] [Full Text] [Related]
34. [The therapeutic value of combined treatment with biguanides and sulfonylurea preparations in the presence of resistance to sulfanilamide drugs in diabetes mellitus patients].
Penchev I; Andreev D; Popov A; Pampulov L
Probl Endokrinol (Mosk); 1970; 16(6):3-7. PubMed ID: 5521087
[No Abstract] [Full Text] [Related]
35. [Oral antidiabetic agents: what are the choices?].
Crausaz FM
Rev Med Suisse Romande; 1991 Aug; 111(8):701-5. PubMed ID: 1925244
[No Abstract] [Full Text] [Related]
36. Modern approach to diabetes mellitus - I.
Stowers JM
Br Med J; 1976 Feb; 1(6008):509-11. PubMed ID: 1252823
[No Abstract] [Full Text] [Related]
37. Drugs for type 2 diabetes.
Treat Guidel Med Lett; 2008 Jul; 6(71):47-54. PubMed ID: 18583949
[No Abstract] [Full Text] [Related]
38. [Treatment of diabetes mellitus with oral antidiabetics].
Froesch ER
Schweiz Med Wochenschr; 1976 Nov; 106(48):1665-7. PubMed ID: 827809
[No Abstract] [Full Text] [Related]
39. Oral management of uncomplicated maturity onset diabetes.
Mashaly M; el-Ebrashy N; Higazi AM; Einen MA; Aziz MT
J Egypt Med Assoc; 1974; 57(7-8):288-97. PubMed ID: 4217809
[No Abstract] [Full Text] [Related]
40. Influence of glycemic control on the development of diabetic cardiovascular and kidney disease.
Saha SA; Tuttle KR
Cardiol Clin; 2010 Aug; 28(3):497-516. PubMed ID: 20621253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
